Emerging Infectious Disease ISSN: 1080-6059

Rhinosporidium seeberi: A Human Pathogen from a Novel Group of Aquatic Protistan Parasites

David N. Fredricks*†

, Jennifer A. Jolley*, Paul W. Lepp*, Jon C. Kosek†, and David A. Relman*†

Author affiliations: *Stanford University, Stanford, California, USA; and †Veterans Affairs, Palo Alto Health Care System, Palo Alto, California, USA

Main Article

Figure 3

Agarose gel electrophoresis of Rhinosporidium-specific PCR products. The specific amplification product is 377 bp. No amplification product is seen in the negative control samples consisting of water (reagent-only control), digestion buffer (DB), or lymph node tissue control (Tis Cnt). The human rhinosporidiosis samples (RS1-3) and the original canine nasal polyp show visible amplification products.

Figure 3. Agarose gel electrophoresis of Rhinosporidium-specific PCR products. The specific amplification product is 377 bp. No amplification product is seen in the negative control samples consisting of water (reagent-only control), digestion buffer (DB), or lymph node tissue control (Tis Cnt). The human rhinosporidiosis samples (RS1-3) and the original canine nasal polyp show visible amplification products.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.